264 related articles for article (PubMed ID: 35459932)
1. Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse.
Dobosz P; Stempor PA; Ramírez Moreno M; Bulgakova NA
Heredity (Edinb); 2022 Jul; 129(1):64-74. PubMed ID: 35459932
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.
Stefansson OA; Jonasson JG; Johannsson OT; Olafsdottir K; Steinarsdottir M; Valgeirsdottir S; Eyfjord JE
Breast Cancer Res; 2009; 11(4):R47. PubMed ID: 19589159
[TBL] [Abstract][Full Text] [Related]
3. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Wen WX; Leong CO
PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in hereditary breast cancer.
Cipollini G; Tommasi S; Paradiso A; Aretini P; Bonatti F; Brunetti I; Bruno M; Lombardi G; Schittulli F; Sensi E; Tancredi M; Bevilacqua G; Caligo MA
Ann Oncol; 2004; 15 Suppl 1():I7-I13. PubMed ID: 15280181
[TBL] [Abstract][Full Text] [Related]
6. The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?
Bertwistle D; Ashworth A
Breast Cancer Res; 1999; 1(1):41-7. PubMed ID: 11250682
[TBL] [Abstract][Full Text] [Related]
7. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
8. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
Staff S; Isola JJ; Johannsson O; Borg A; Tanner MM
Br J Cancer; 2001 Oct; 85(8):1201-5. PubMed ID: 11710835
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
[TBL] [Abstract][Full Text] [Related]
10. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
11. Gene-expression profiles in hereditary breast cancer.
Hedenfalk I; Duggan D; Chen Y; Radmacher M; Bittner M; Simon R; Meltzer P; Gusterson B; Esteller M; Kallioniemi OP; Wilfond B; Borg A; Trent J; Raffeld M; Yakhini Z; Ben-Dor A; Dougherty E; Kononen J; Bubendorf L; Fehrle W; Pittaluga S; Gruvberger S; Loman N; Johannsson O; Olsson H; Sauter G
N Engl J Med; 2001 Feb; 344(8):539-48. PubMed ID: 11207349
[TBL] [Abstract][Full Text] [Related]
12. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
13. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
Bonadona V; Lasset C
Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
[TBL] [Abstract][Full Text] [Related]
14. Inherited breast cancer: an emerging picture.
Welcsh PL; Schubert EL; King MC
Clin Genet; 1998 Dec; 54(6):447-58. PubMed ID: 9894790
[TBL] [Abstract][Full Text] [Related]
15. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
16. Cancer morphology, carcinogenesis and genetic instability: a background.
Bignold LP; Coghlan BL; Jersmann HP
EXS; 2006; (96):1-24. PubMed ID: 16383012
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
18. Inherited mutations in breast cancer genes--risk and response.
Shuen AY; Foulkes WD
J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):3-15. PubMed ID: 21461995
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
Welcsh PL; King MC
Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
